Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Through the Cracks: Niche Patient Population Battles Dermatopathologic Complications of Rheumatic Disease
-
- Biomarkers in Early and Post-traumatic Osteoarthritis Ariel M. Bodker, MD; Susan Chubinskaya, PhD; Christian Lattermann, MD
- Five Top Stories From the Biologic Therapies VII Summit
- FDA Approves Biosimilar for Infliximab
- FDA Unable to Grant Approval for Baricitinib’s New Drug Application
- Giant Cell Arteritis: What a Long Strange Trip It Has Been Leonard H. Calabrese, DO
- Closer Look at Giant Cell Arteritis
- Inflammation Can Be Controlled With a Careful Rheumatoid Arthritis Diet
- Sjögren’s Syndrome Foundation Releases its First Guidelines for Disease Treatment
-
- Real-world Belimumab Reduced Disease Activity in Patients With Lupus
- Tofacitinib Combination Therapy led to Improvements in Patient-reported Outcomes
- VIDEO: Torgerson Discusses Discovery of Single-gene Defects in Immunodeficiency Diseases
- Kavanaugh Reviews Treatment Discontinuation Data for RA
- Specks Describes Unmet Needs in Management of Granulomatosis With Polyangiitis, Microscopic Polyangiitis
- VIDEO: Holers Discusses Prevention of Rheumatoid Arthritis
- Report: Targeted DMARDs Need to Have Discounts to be Cost-effective for RA